Atta Behfar, M.D., Ph.D., CEO
Rochester, MN
Rion is a clinical-stage biotech company that has established a platelet-based exosome therapeutic platform, call Purified Exosome Product (PEP), as the first-ever fully off-the-shelf regenerative medicine with widespread tissue healing application. Rion has developed PEP into a clinic-ready therapeutic that can be cGMP manufactured with high consistency, and demonstrated PEP’s safety, efficacy, and reproducibility in numerous preclinical animal studies across many types of tissue, including heart, muscle, skin, tendon, and nerve. Rion is working with research collaborators to establish efficacy in additional applications such as other cardiovascular diseases, women’s health, COPD, tendon repair, and nerve regeneration.

By using this website you agree to accept our Privacy Policy and Terms & Conditions